41.60 (-%)
As of Dec 10, 2024
Source:
Protagonist Therapeutics, Inc are a biopharmaceutical company with peptide-based new chemical entities rusfertide and JNJ-2113 in different stages of development, all derived from our proprietary discovery technology platform.
Country | United States |
Headquarters | newark, california |
Phone Number | (510) 474-0170 |
Industry | manufacturing |
CEO | Dinesh V. Patel, Ph.D. |
Website | www.protagonist-inc.com |